Transplantation of fecal microbiota from patients with irritable bowel syndrome alters gut function and behavior in recipient mice

Science Translational Medicine

Volumn 9, Issue 379, 2017, Pages

  De Palma, Giada ^a   Lynch, Michael D J ^b   Lu, Jun ^a   Dang, Vi T ^c   Deng, Yikang ^a   Jury, Jennifer ^a   Umeh, Genevieve ^a   Miranda, Pedro M ^a   Pastor, Marc Pigrau ^a   Sidani, Sacha ^a   Pinto Sanchez, Maria Ines ^a   Philip, Vivek ^a   McLean, Peter G ^d   Hagelsieb, Moreno Gabriel ^e   Surette, Michael G ^a   Bergonzelli, Gabriela E ^d   Verdu, Elena F ^a   Britz McKibbin, Philip ^c   Neufeld, Josh D ^b   Collins, Stephen M ^a   Bercik, Premysl ^a   more..

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF WATERLOO   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d NESTLÉ RESEARCH CENTER   (Switzerland)

^e WILFRID LAURIER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA DEFENSIN 3; C REACTIVE PROTEIN; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR4; COMPLEMENT COMPONENT C3; GAMMA INTERFERON; GLUCOCORTICOID RECEPTOR; GLYCEROPHOSPHORYLCHOLINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; LYSOPHOSPHATIDYLCHOLINE; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; OLEIC ACID; PALMITIC ACID; PATTERN RECOGNITION RECEPTOR; PHOSPHATIDYLSERINE; STEARIC ACID; TUMOR NECROSIS FACTOR;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; CD3+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; FECAL MICROBIOTA TRANSPLANTATION; FEMALE; GASTROINTESTINAL TRANSIT; GENE EXPRESSION REGULATION; GERMFREE MOUSE; HUMAN; INNATE IMMUNITY; INTESTINE FUNCTION; INTESTINE MOTILITY; INTESTINE MUCOSA PERMEABILITY; IRRITABLE COLON; LYMPHOCYTE COUNT; MALE; MOUSE; NONHUMAN; RECIPIENT; SWISS WEBSTER MOUSE; UPREGULATION; ANIMAL; ANIMAL BEHAVIOR; BLOOD; CASE CONTROL STUDY; COLON; DONOR; FECES; GASTROINTESTINAL TRACT; GERMFREE ANIMAL; IMMUNOLOGY; INTESTINE FLORA; METABOLISM; METABOLOMICS; MICROBIOLOGY; PATHOPHYSIOLOGY;

ADULT; ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; CASE-CONTROL STUDIES; COLON; FECAL MICROBIOTA TRANSPLANTATION; FECES; FEMALE; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; GASTROINTESTINAL TRANSIT; GERM-FREE LIFE; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; METABOLOMICS; MICE; TISSUE DONORS;

EID: 85014649400     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.aaf6397     Document Type: Article

References (96)

1. I. Sekirov, S. L. Russell, L. C. M. Antunes, B. B. Finlay, Gut microbiota in health and disease. Physiol. Rev. 90, 859-904 (2010).
2. L. V. Hooper, D. R. Littman, A. J. Macpherson, Interactions between the microbiota and the immune system. Science 336, 1268-1273 (2012).
3. E. Husebye, P. M. Hellström, F. Sundler, J. Chen, T. Midtvedt, Influence of microbial species on small intestinal myoelectric activity and transit in germ-free rats. Am. J. Physiol. Gastrointest. Liver Physiol. 280, G368-G380 (2001).
4. V. K. Ridaura, J. J. Faith, F. E. Rey, J. Cheng, A. E. Duncan, A. L. Kau, N. W. Griffin, V. Lombard, B. Henrissat, J. R. Bain, M. J. Muehlbauer, O. Ilkayeva, C. F. Semenkovich, K. Funai, D. K. Hayashi, B. J. Lyle, M. C. Martini, L. K. Ursell, J. C. Clemente, W. Van Treuren, W. A. Walters, R. Knight, C. B. Newgard, A. C. Heath, J. I. Gordon, Gut microbiota from twins discordant for obesity modulate metabolism in mice Science 341, 1241214 (2013).
5. E. F. Verdú, P. Bercik, M. Verma-Gandhu, X.-X. Huang, P. Blennerhassett, W. Jackson, Y. Mao, L. Wang, F. Rochat, S. M. Collins, Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice. Gut 55, 182-190 (2006).
6. M. Nieuwdorp, P. W. Gilijamse, N. Pai, L. M. Kaplan, Role of the microbiome in energy regulation and metabolism. Gastroenterology 146, 1525-1533 (2014).
7. B. Schnabl, D. A. Brenner, Interactions between the intestinal microbiome and liver diseases. Gastroenterology 146, 1513-1524 (2014).
8. F. A. Amaral, D. Sachs, V. V. Costa, C. T. Fagundes, D. Cisalpino, T. M. Cunha, S. H. Ferreira, F. Q. Cunha, T. A. Silva, J. R. Nicoli, L. Q. Vieira, D. G. Souza, M. M. Teixeira, Commensal microbiota is fundamental for the development of inflammatory pain. Proc. Natl. Acad. Sci. U.S.A. 105, 2193-2197 (2008).
9. R. D. Heijtz, S. Wang, F. Anuar, Y. Qian, B. Björkholm, A. Samuelsson, M. L. Hibberd, H. Forssberg, S. Pettersson, Normal gut microbiota modulates brain development and behavior. Proc. Natl. Acad. Sci. U.S.A. 108, 3047-3052 (2011).
10. P. Bercik, E. Denou, J. Collins, W. Jackson, J. Lu, J. Jury, Y. Deng, P. Blennerhassett, J. Macri, K. D. McCoy, E. F. Verdu, S. M. Collins, The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology 141, 599-609.e3 (2011).
11. M. G. Gareau, E. Wine, D. M. Rodrigues, J. H. Cho, M. T. Whary, D. J. Philpott, G. Macqueen, P. M. Sherman, Bacterial infection causes stress-induced memory dysfunction in mice. Gut 60, 307-317 (2011).
12. J. A. Bravo, P. Forsythe, M. V. Chew, E. Escaravage, H. M. Savignac, T. G. Dinan, J. Bienenstock, J. F. Cryan, Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc. Natl. Acad. Sci. U.S.A. 108, 16050-16055 (2011).
13. S. M. Collins, M. Surette, P. Bercik, The interplay between the intestinal microbiota and the brain. Nat. Rev. Microbiol. 10, 735-742 (2012).
14. D. A. Peterson, D. N. Frank, N. R. Pace, J. I. Gordon, Metagenomic approaches for defining the pathogenesis of inflammatory bowel diseases. Cell Host Microbe 3, 417-427 (2008).
15. P. Bhargava, E. M. Mowry, Gut microbiome and multiple sclerosis. Curr. Neurol. Neurosci. Rep. 14, 492 (2014).
16. J. G. Mulle, W. G. Sharp, J. F. Cubells, The gut microbiome: A new frontier in autism research. Curr. Psychiatry Rep. 15, 337 (2013).
17. W. P. Hanage, Microbiology: Microbiome science needs a healthy dose of scepticism. Nature 512, 247-248 (2014).
18. D. A. Drossman, M. Camilleri, E. A. Mayer, W. E. Whitehead, AGA technical review on irritable bowel syndrome. Gastroenterology 123, 2108-2131 (2002).
19. G. F. Longstreth, W. G. Thompson, W. D. Chey, L. A. Houghton, F. Mearin, R. C. Spiller, Functional bowel disorders. Gastroenterology 130, 1480-1491 (2006).
20. G. Fond, A. Loundou, N. Hamdani, W. Boukouaci, A. Dargel, J. Oliveira, M. Roger, R. Tamouza, M. Leboyer, L. Boyer, Anxiety and depression comorbidities in irritable bowel syndrome (IBS): A systematic review and meta-analysis. Eur. Arch. Psychiatry Clin. Neurosci. 264, 651-660 (2014).
21. M. Simrén, G. Barbara, H. J. Flint, B. M. R. Spiegel, R. C. Spiller, S. Vanner, E. F. Verdu, P. J. Whorwell, E. G. Zoetendal, Intestinal microbiota in functional bowel disorders: A Rome foundation report. Gut 62, 159-176 (2013).
22. J. Mättö, L. Maunuksela, K. Kajander, A. Palva, R. Korpela, A. Kassinen, M. Saarela, Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome - A longitudinal study in IBS and control subjects. FEMS Immunol. Med. Microbiol. 43, 213-222 (2005).
23. C Tana, Y. Umesaki, A. Imaoka, T. Handa, M. Kanazawa, S. Fukudo, Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome. Neurogastroenterol. Motil. 22, 512-519, e114-115 (2010).
24. I. B. Jeffery, P. W. O'Toole, L. Öhman, M. J. Claesson, J. Deane, E. M. M. Quigley, M. Simrén, An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota. Gut 61, 997-1006 (2012).
25. I. M. Carroll, T. Ringel-Kulka, J. P. Siddle, Y. Ringel, Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome. Neurogastroenterol. Motil. 24, 521-530.e248 (2012).
26. L Krogius-Kurikka, A. Lyra, E. Malinen, J. Aarnikunnas, J. Tuimala, L. Paulin, H. Mäkivuokko, K. Kajander, A. Palva, Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers. BMC Gastroenterol. 9, 95 (2009).
27. R. Spiller, K. Garsed, Postinfectious irritable bowel syndrome. Gastroenterology 136, 1979-1988 (2009).
28. A. A. Villarreal, F. J. Aberger, R. Benrud, J. D. Gundrum, Use of broad-spectrum antibiotics and the development of irritable bowel syndrome. WMJ 111, 17-20 (2012).
29. M. El-Salhy, H. Østgaard, D. Gundersen, J. G. Hatlebakk, T. Hausken, The role of diet in the pathogenesis and management of irritable bowel syndrome (Review). Int. J. Mol. Med. 29, 723-731 (2012).
30. S. P. Dunlop, N. S. Coleman, E. Blackshaw, A. C. Perkins, G. Singh, C. A. Marsden, R. C. Spiller, Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome. Clin. Gastroenterol. Hepatol. 3, 349-357 (2005).
31. A. C. Ford, N. J. Talley, Mucosal inflammation as a potential etiological factor in irritable bowel syndrome: A systematic review. J. Gastroenterol. 46, 421-431 (2011).
32. T. Liebregts, B. Adam, C. Bredack, A. Röth, S. Heinzel, S. Lester, S. Downie-Doyle, E. Smith, P. Drew, N. J. Talley, G. Holtmann, Immune activation in patients with irritable bowel syndrome. Gastroenterology 132, 913-920 (2007).
33. D. E. Reed, M. Pigrau, J. Lu, P. Mayyedi, S. M. Collins, P. Bercik, Beads study: A novel method to measure gastrointestinal transit in mice. Neurogastroenterol. Motil. 26, 1663-1668 (2014).
34. N. J. Talley, Functional gastrointestinal disorders in 2007 and Rome III: Something new, something borrowed, something objective. Rev. Gastroenterol. Disord. 7, 97-105 (2007).
35. W. E. Whitehead, O. Palsson, K. R. Jones, Systematic review of the comorbidity of irritable bowel syndrome with other disorders: What are the causes and implications? Gastroenterology 122, 1140-1156 (2002).
36. E. Voss, J. Wehkamp, K. Wehkamp, E. F. Stange, J. M. Schröder, J. Harder, NOD2/CARD15 mediates induction of the antimicrobial peptide human beta-defensin-2. J. Biol. Chem. 281, 2005-2011 (2006).
37. J. Wehkamp, K. Fellermann, K. R. Herrlinger, S. Baxmann, K. Schmidt, B. Schwind, M. Duchrow, C. Wohlschläger, A. C. Feller, E. F. Stange, Human beta-defensin 2 but not beta-defensin 1 is expressed preferentially in colonic mucosa of inflammatory bowel disease. Eur. J. Gastroenterol. Hepatol. 14, 745-752 (2002).
38. J. Langhorst, A. Junge, A. Rueffer, J. Wehkamp, D. Foell, A. Michalsen, F. Musial, G. J. Dobos, Elevated human β-defensin-2 levels indicate an activation of the innate immune system in patients with irritable bowel syndrome. Am. J. Gastroenterol. 104, 404-410 (2009).
39. + T cells are required to activate inflammatory monocytes for defense against intestinal infection. PLOS Pathog. 9, e1003706 (2013).
40. A. E. Østvik, A. V. Granlund, M. Bugge, N. J. Nilsen, S. H. Torp, H. L. Waldum, J. K. Damås, T. Espevik, A. K. Sandvik, Enhanced expression of CXCL10 in inflammatory bowel disease: Potential role of mucosal Toll-like receptor 3 stimulation. Inflamm. Bowel Dis. 19, 265-274 (2013).
41. G. Moloney, A. Fanning, J. M. Sharry, O. F. Craig, E. Edelstein, T. G. Dinan, J. F. Cryan, F. Shanahan, E. M. Quigley, S. Melgar, K. Nally, Evidence of on-going activation of the CXCR3 chemokine system in Irritable Bowel Syndrome (IBS). Gastroenterology 146, S-530-S-531 (2014).
42. A. Salonen, W. M. de Vos, A. Palva, Gastrointestinal microbiota in irritable bowel syndrome: Present state and perspectives. Microbiology 156, 3205-3215 (2010).
43. C. Martínez, M. Vicario, L. Ramos, B. Lobo, J. L. Mosquera, C. Alonso, A. Sánchez, M. Guilarte, M. Antolín, I. de Torres, A. M. González-Castro, M. Pigrau, E. Saperas, F. Azpiroz, J. Santos, The jejunum of diarrhea-predominant irritable bowel syndrome shows molecular alterations in the tight junction signaling pathway that are associated with mucosal pathobiology and clinical manifestations. Am. J. Gastroenterol. 107, 736-746 (2012).
44. P. Bercik, E. F. Verdu, J. A. Foster, J. Macri, M. Potter, X. Huang, P. Malinowski, W. Jackson, P. Blennerhassett, K. A. Neufeld, J. Lu, W. I. Khan, I. Corthesy-Theulaz, C. Cherbut, G. E. Bergonzelli, S. M. Collins, Chronic gastrointestinal inflammation induces anxiety-like behavior and alters central nervous system biochemistry in mice. Gastroenterology 139, 2102-2112.e1 (2010).
45. K. Tillisch, J. Labus, L. Kilpatrick, Z. Jiang, J. Stains, B. Ebrat, D. Guyonnet, S. Legrain-Raspaud, B. Trotin, B. Naliboff, E. A. Mayer, Consumption of fermented milk product with probiotic modulates brain activity. Gastroenterology 144, 1394-1401.e4 (2013).
46. M. I. Pinto-Sanchez, G. Hall, K. Gajar, A. Nardelli, C. Bolino, C. Welch, A. Rieder, J. Traynor, C. Gregory, J. Lau, A. C. Ford, G. Bergonzelli, M. G. Surette, S. M. Collins, P. Moayyedi, P. Bercik, Bifidobacterium longum NCC3001 improves depression scores and alters brain activity in patients with Irritable bowel syndrome: A randomized, double blind, placebo-controlled trial. UEG Proc. J. 3 (suppl. 1), 2050 (2015).
47. M. Camilleri, Peripheral mechanisms in irritable bowel syndrome. N. Engl. J. Med. 367, 1626-1635 (2012).
48. N. Radojevic, D. M. McKay, M. Merger, B. A. Vallance, S. M. Collins, K. Croitoru, Characterization of enteric functional changes evoked by in vivo anti-CD3 T cell activation. Am. J. Physiol. 276, R715-R723 (1999).
49. C. Ibeakanma, F. Ochoa-Cortes, M. Miranda-Morales, T. McDonald, I. Spreadbury, N. Cenac, F. Cattaruzza, D. Hurlbut, S. Vanner, N. Bunnett, N. Vergnolle, S. Vanner, Brain-gut interactions increase peripheral nociceptive signaling in mice with postinfectious irritable bowel syndrome. Gastroenterology 141, 2098-2108.e5 (2011).
50. L. Tran, A. Chaloner, A. H. Sawalha, B. Greenwood Van-Meerveld, Importance of epigenetic mechanisms in visceral pain induced by chronic water avoidance stress. Psychoneuroendocrinology 38, 898-906 (2013).
51. J. Röhrl, D. Yang, J. J. Oppenheim, T. Hehlgans, Human β-defensin 2 and 3 and their mouse orthologs induce chemotaxis through interaction with CCR2. J. Immunol. 184, 6688-6694 (2010).
52. A. Oeckinghaus, M. S. Hayden, S. Ghosh, Crosstalk in NF-κB signaling pathways. Nat. Immunol. 12, 695-708 (2011).
53. L. R. Avula, D. Knapen, R. Buckinx, L. Vergauwen, D. Adriaensen, L. Van Nassauw, J.-P. Timmermans, Whole-genome microarray analysis and functional characterization reveal distinct gene expression profiles and patterns in two mouse models of ileal inflammation. BMC Genomics 13, 377 (2012).
54. G. Barbara, R. De Giorgio, V. Stanghellini, C. Cremon, B. Salvioli, R. Corinaldesi, New pathophysiological mechanisms in irritable bowel syndrome. Aliment. Pharmacol. Ther. 20 (suppl. 2), 1-9 (2004).
55. R. Al-Sadi, S. Guo, D. Ye, K. Dokladny, T. Alhmoud, L. Ereifej, H. M. Said, T. Y. Ma, Mechanism of IL-1β modulation of intestinal epithelial barrier involves p38 kinase and activating transcription factor-2 activation. J. Immunol. 190, 6596-6606 (2013).
56. R. Sano, J. C. Reed, ER stress-induced cell death mechanisms. Biochim. Biophys. Acta 1833, 3460-3470 (2013).
57. E. S. Wohleb, N. D. Powell, J. P. Godbout, J. F. Sheridan, Stress-induced recruitment of bone marrow-derived monocytes to the brain promotes anxiety-like behavior. J. Neurosci. 33, 13820-13833 (2013).
58. M. Rajilić-Stojanović, E. Biagi, H. G. H. J. Heilig, K. Kajander, R. A. Kekkonen, S. Tims, W. M. de Vos, Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology 141, 1792-1801 (2011).
59. D. M. Saulnier, K. Riehle, T.-A. Mistretta, M.-A. Diaz, D. Mandal, S. Raza, E. M. Weidler, X. Qin, C. Coarfa, A. Milosavljevic, J. F. Petrosino, S. Highlander, R. Gibbs, S. V. Lynch, R. J. Shulman, J. Versalovic, Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome. Gastroenterology 141, 1782-1791 (2011).
60. B. Fuchs, K. Muller, U. Paasch, J. Schiller, Lysophospholipids: Potential markers of diseases and infertility? Mini Rev. Med. Chem. 12, 74-86 (2012).
61. H. Fan, B. Zingarelli, V. Harris, G. E. Tempel, P. V. Halushka, J. A. Cook, Lysophosphatidic acid inhibits bacterial endotoxin-induced pro-inflammatory response: Potential anti-inflammatory signaling pathways. Mol. Med. 14, 422-428 (2008).
62. B. Frey, U. S. Gaipl, The immune functions of phosphatidylserine in membranes of dying cells and microvesicles. Semin. Immunopathol. 33, 497-516 (2011).
63. J. Hellhammer, E. Fries, C. Buss, V. Engert, A. Tuch, D. Rutenberg, D. Hellhammer, Effects of soy lecithin phosphatidic acid and phosphatidylserine complex (PAS) on the endocrine and psychological responses to mental stress. Stress 7, 119-126 (2004).
64. E. W. Fünfgeld, M. Baggen, P. Nedwidek, B. Richstein, G. Mistlberger, Double-blind study with phosphatidylserine (PS) in parkinsonian patients with senile dementia of Alzheimer's type (SDAT). Prog. Clin. Biol. Res. 317, 1235-1246 (1989).
65. J. C. Castilho, J. C. Perry, R. Andreatini, M. A. B. F. Vital, Phosphatidylserine: An antidepressive or a cognitive enhancer? Prog. Neuropsychopharmacol. Biol. Psychiatry 28, 731-738 (2004).
66. F. Brambilla, M. Maggioni, Blood levels of cytokines in elderly patients with major depressive disorder. Acta Psychiatr. Scand. 97, 309-313 (1998).
67. A. Vanotti, M. Osio, E. Mailland, C. Nascimbene, E. Capiluppi, C. Mariani, Overview on pathophysiology and newer approaches to treatment of peripheral neuropathies. CNS Drugs 21 (suppl. 1), 3-12; discussion 45-46 (2007).
68. J. W. Pettegrew, J. Levine, R. J. McClure, Acetyl-L-carnitine physical-chemical, metabolic, and therapeutic properties: Relevance for its mode of action in Alzheimer's disease and geriatric depression. Mol. Psychiatry 5, 616-632 (2000).
69. S. C. Benoit, C. J. Kemp, C. F. Elias, W. Abplanalp, J. P. Herman, S. Migrenne, A.-L. Lefevre, C. Cruciani-Guglielmacci, C. Magnan, F. Yu, K. Niswender, B. G. Irani, W. L. Holland, D. J. Clegg, Palmitic acid mediates hypothalamic insulin resistance by altering PKC-θ subcellular localization in rodents. J. Clin. Invest. 119, 2577-2589 (2009).
70. M. De Jesus Moreno Moreno, Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: A multicenter, double-blind, randomized, placebo-controlled trial. Clin. Ther. 25, 178-193 (2003).
71. L. Parnetti, F. Mignini, D. Tomassoni, E. Traini, F. Amenta, Cholinergic precursors in the treatment of cognitive impairment of vascular origin: Ineffective approaches or need for re-evaluation? J. Neurol. Sci. 257, 264-269 (2007).
72. M. T. Bailey, S. E. Dowd, N. M. A. Parry, J. D. Galley, D. B. Schauer, M. Lyte, Stressor exposure disrupts commensal microbial populations in the intestines and leads to increased colonization by Citrobacter rodentium. Infect. Immun. 78, 1509-1519 (2010).
73. A. J. Park, J. Collins, P. A. Blennerhassett, J. E. Ghia, E. F. Verdu, P. Bercik, S. M. Collins, Altered colonic function and microbiota profile in a mouse model of chronic depression. Neurogastroenterol. Motil. 25, 733-e575 (2013).
74. H. Anisman, S. Hayley, O. Kelly, T. Borowski, Z. Merali, Psychogenic, neurogenic, and systemic stressor effects on plasma corticosterone and behavior: Mouse strain-dependent outcomes. Behav. Neurosci. 115, 443-454 (2001).
75. M. Bourin, M. Hascoët, The mouse light/dark box test. Eur. J. Pharmacol. 463, 55-65 (2003).
76. B. Šakić, H. Szechtman, H. Talangbayan, S. D. Denburg, R. M. Carbotte, J. A. Denburg, Disturbed emotionality in autoimmune MRL-lpr mice. Physiol. Behav. 56, 609-617 (1994).
77. H. J. Galipeau, N. E. Rulli, J. Jury, X. Huang, R. Araya, J. A. Murray, C. S. David, F. G. Chirdo, K. D. McCoy, E. F. Verdu, Sensitization to gliadin induces moderate enteropathy and insulitis in nonobese diabetic-DQ8 mice. J. Immunol. 187, 4338-4346 (2011).
78. K. Kennedy, M. W. Hall, M. D. J. Lynch, G. Moreno-Hagelsieb, J. D. Neufeld, Evaluating bias of illumina-based bacterial 16S rRNA gene profiles. Appl. Environ. Microbiol. 80, 5717-5722 (2014).
79. A. K. Bartram, M. D. J. Lynch, J. C. Stearns, G. Moreno-Hagelsieb, J. D. Neufeld, Generation of multimillion-sequence 16S rRNA gene libraries from complex microbial communities by assembling paired-end illumina reads. Appl. Environ. Microbiol. 77, 3846-3852 (2011).
80. M. D. J. Lynch, A. P. Masella, M. W. Hall, A. K. Bartram, J. D. Neufeld, AXIOME: Automated exploration of microbial diversity. GigaScience 2, 3 (2013).
81. J. G. Caporaso, J. Kuczynski, J. Stombaugh, K. Bittinger, F. D. Bushman, E. K. Costello, N. Fierer, A. G. Peña, J. K. Goodrich, J. I. Gordon, G. A. Huttley, S. T. Kelley, D. Knights, J. E. Koenig, R. E. Ley, C. A. Lozupone, D. McDonald, B. D. Muegge, M. Pirrung, J. Reeder, J. R. Sevinsky, P. J. Turnbaugh, W. A. Walters, J. Widmann, T. Yatsunenko, J. Zaneveld, R. Knight, QIIME allows analysis of high-throughput community sequencing data. Nat. Methods 7, 335-336 (2010).
82. A. P. Masella, A. K. Bartram, J. M. Truszkowski, D. G. Brown, J. D. Neufeld, PANDAseq: Paired-end assembler for illumina sequences. BMC Bioinformatics 13, 31 (2012).
83. R. C. Edgar, UPARSE: Highly accurate OTU sequences from microbial amplicon reads. Nat. Methods 10, 996-998 (2013).
84. Q. Wang, G. M. Garrity, J. M. Tiedje, J. R. Cole, Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl. Environ. Microbiol. 73, 5261-5267 (2007).
85. T. Z. DeSantis, P. Hugenholtz, N. Larsen, M. Rojas, E. L. Brodie, K. Keller, T. Huber, D. Dalevi, P. Hu, G. L. Andersen, Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl. Environ. Microbiol. 72, 5069-5072 (2006).
86. D. McDonald, M. N. Price, J. Goodrich, E. P. Nawrocki, T. Z. DeSantis, A. Probst, G. L. Andersen, R. Knight, P. Hugenholtz, An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea. ISME J. 6, 610-618 (2012).
87. R. C. Edgar, B. J. Haas, J. C. Clemente, C. Quince, R. Knight, UCHIME improves sensitivity and speed of chimera detection. Bioinformatics 27, 2194-2200 (2011).
88. P. W. Mielke Jr., Meteorological applications of permutation techniques based on distance function, in Handbook of Statistics, P. R. Krishnaiah, P. K. Sen, Eds. (Elsevier, 1984), vol. 4, pp. 813-830.
89. C. Lozupone, R. Knight, UniFrac: A new phylogenetic method for comparing microbial communities. Appl. Environ. Microbiol. 71, 8228-8235 (2005).
90. M. N. Price, P. S. Dehal, A. P. Arkin, FastTree 2-approximately maximum-likelihood trees for large alignments. PLOS ONE 5, e9490 (2010).
91. M. N. Price, P. S. Dehal, A. P. Arkin, FastTree: Computing large minimum evolution trees with profiles instead of a distance matrix. Mol. Biol. Evol. 26, 1641-1650 (2009).
92. J. G. Caporaso, K. Bittinger, F. D. Bushman, T. Z. DeSantis, G. L. Andersen, R. Knight, PyNAST: A flexible tool for aligning sequences to a template alignment. Bioinformatics 26, 266-267 (2010).
93. M. Dufrêne, P. Legendre, Species assemblages and indicator species: The need for a flexible asymmetrical approach. Ecol. Monogr. 67, 345-366 (1997).
94. J. Walter, G. W. Tannock, A. Tilsala-Timisjarvi, S. Rodtong, D. M. Loach, K. Munro, T. Alatossava, Detection and identification of gastrointestinal Lactobacillus species by using denaturing gradient gel electrophoresis and species-specific PCR primers. Appl. Environ. Microbiol. 66, 297-303 (2000).
95. K. R. Chalcraft, B. E. McCarry, Tandem LC columns for the simultaneous retention of polar and nonpolar molecules in comprehensive metabolomics analysis. J. Sep. Sci. 36, 3478-3485 (2013).
96. C. A. Smith, E. J. Want, G. O'Maille, R. Abagyan, G. Siuzdak, XCMS: Processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Anal. Chem. 78, 779-787 (2006).